Try to Continue Asenapine or Lumateperone on Admission

April 2020

Patients may be on new atypical antipsychotics...asenapine (Secuado, seh-KWAH-doh) or lumateperone (Caplyta, kah-PLY-tah).

There are now over a dozen of these second-generation options...with varying activity at receptors (dopamine, serotonin, etc). But efficacy seems similar.

If patients are on an asenapine patch or lumateperone at home for schizophrenia, try to continue it on admission.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote